查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829395

2025年全球氣霧劑輸送設備市場報告

Aerosol Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，氣霧劑輸送設備市場規模強勁成長，從2024年的476億美元成長到2025年的512.4億美元，複合年成長率為7.7%。預測期內的成長歸因於呼吸系統疾病盛行率的上升、監管部門的核准、行動裝置的普及、醫療保健支出的增加、呼吸健康宣傳宣傳活動的加強、政府舉措以及資金籌措。

預計未來幾年氣霧劑輸送設備市場規模將強勁成長，2029年將達到689.4億美元，複合年成長率為7.7%。預測期內的成長可歸因於慢性病管理應用的不斷擴展、研發投入的不斷增加、個人化醫療需求的不斷成長、空氣污染水平的上升導致呼吸系統疾病的增多，以及人口老齡化推動呼吸系統治療需求的成長。預測期內的主要趨勢包括技術進步、藥物輸送系統的改進、學名藥的推出、用於吸入療法的生技藥品和特種藥物的開發，以及用於氣霧劑藥物輸送的奈米技術的進步。

氣霧劑輸送裝置是一種專門設計的醫療器械，旨在將藥物以霧狀或氣霧狀的形式直接輸送至肺部。這類裝置透過精準輸送治療藥物，在治療呼吸系統疾病方面扮演重要角色。其主要目的是確保藥物在呼吸系統內有效且有針對性的分佈。

氣霧劑輸送裝置有多種類型，包括乾粉吸入器、定量吸入器和霧化器。乾粉吸入器釋放粉末狀藥物，由使用者呼吸激活，用於治療氣喘、慢性阻塞性肺病、囊腫纖維化和其他非呼吸系統疾病。這些裝置通常透過零售藥局、醫院藥局和電商平台銷售。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告隸屬於一家商業研究公司發布的一系列新報告，該系列報告提供氣霧劑輸送設備市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的氣霧劑輸送設備細分市場、市場趨勢和商機，以及您在氣霧劑輸送設備行業取得成功所需的數據。本氣霧劑輸送設備市場研究報告對該行業的現狀和未來走勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長7.7%，較先前預測略有下降0.5%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，導致日本精密超音波霧化器和以色列劑量計數儀的成本上升，從而增加呼吸系統疾病的管理成本。此外，互惠關稅以及貿易緊張局勢和限制升級對全球經濟和貿易的負面影響也將更廣泛地體現出來。

呼吸系統疾病盛行率的上升預計將推動氣霧劑輸送裝置市場的成長。這些疾病涵蓋影響呼吸道、肺部和呼吸系統的各種疾病，由空氣污染、吸煙、過敏原和呼吸道感染疾病等因素引起。氣霧輸送裝置在治療呼吸系統疾病方面發揮關鍵作用，它能有效地將支氣管擴張劑和皮質類固醇等藥物直接輸送到肺部，改善治療效果和患者依從性。根據美國國家衛生統計中心 (NCHS) 2024 年 5 月的數據，預計美國成年人氣喘的盛行率將從 2021 年的 8% 上升到 2022 年的 8.7%，同期氣喘發作率也將從 3.3% 上升到 3.7%。因此，呼吸系統疾病盛行率的上升預計將推動氣霧劑輸送裝置市場的發展。

氣霧劑輸送裝置市場的主要參與者正致力於開發創新的吸入器劑量追蹤器，透過使用者友善的設計來提高藥物依從性。這些智慧追蹤器配備感測器和連接功能，可即時監測藥物狀態，提高依從性並為患者和醫療保健提供者提供全面的數據。例如，2024 年 6 月，英國醫療科技公司 Aseptika Ltd. 推出了 PUFFClicker3 通用吸入器，這是一款與各種吸入器相容的開創性智慧吸入器劑量計數器。 PUFFClicker3 通用吸入器是一款與各種吸入器相容的開創性智慧吸入器劑量計數器。它使用感測器記錄每次劑量，提供即時監控，具有方便用戶使用的介面，並透過藍牙連接與健康應用程式同步。這項技術創新可幫助患者遵守用藥計劃，同時為醫療保健提供者提供有價值的用藥依從性資訊。

2024年1月，美國製藥公司Kindeva Drug Delivery收購了高峰會 Biosciences，收購金額未揭露。此次收購旨在擴大Kindeva在藥物傳輸技術領域的產品組合，專注於無菌製劑和滴鼻劑。透過整合高峰會 Biosciences， 高峰會旨在鞏固其市場地位，並增強技術力。 Summit Biosciences也位於美國，專門生產包括滴鼻劑在內的氣霧劑輸送裝置。

氣霧劑輸送裝置市場包括緩霧吸入器、儲霧罐、呼吸驅動吸入器和局部噴霧瓶的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球氣霧劑輸送裝置：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球氣霧劑輸送裝置市場：成長率分析
  • 全球氣霧劑輸送裝置市場表現：規模與成長，2019-2024
  • 全球氣霧劑輸送裝置市場預測：規模與成長，2024-2029 年，2034 年
  • 全球氣霧劑輸送裝置：總目標市場（TAM）

第6章 市場細分

  • 全球氣霧劑輸送設備市場：依產品、性能及預測，2019-2024 年、2024-2029 年、2034 年
  • 乾粉吸入器
  • 定量噴霧吸入器
  • 噴霧器
  • 全球氣霧劑輸送裝置市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 氣喘
  • 慢性阻塞性肺病
  • 囊腫纖維化
  • 非呼吸系統疾病
  • 全球氣霧劑輸送裝置市場：依通路、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 零售藥局
  • 醫院藥房
  • 電子商務
  • 全球氣霧劑輸送設備市場：按乾粉吸入器 (DPI) 細分，類型，實際和預測，2019-2024 年，2024-2029 年，2034 年
  • 單劑量DPI
  • 多劑量DPI
  • 全球氣霧劑輸送裝置市場：定量噴霧吸入器(MDI) 細分，類型，性能和預測，2019-2024 年，2024-2029 年，2034 年
  • 常規MDI
  • 間隔/腔式 MDI
  • 全球氣霧劑輸送設備市場：按霧化器類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 噴射霧化器
  • 超音波霧化器
  • 網狀霧化器

第7章 區域和國家分析

  • 全球氣霧劑輸送裝置市場：區域分析、預測與成長，2019-2024 年、2024-2029 年、2034 年
  • 全球氣霧劑輸送裝置市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 氣霧劑輸送裝置市場：競爭格局
  • 氣霧劑輸送裝置市場：公司簡介
    • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • GlaxoSmithKline plc（GSK）
  • 3M Company
  • Becton Dickinson and Company
  • Koninklijke Philips NV
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Draegerwerk AG & Co KGaA
  • Shionogi & Co Ltd
  • Hikma Pharmaceuticals PLC
  • Chiesi Farmaceutici SpA
  • Vectura Group plc
  • Fresenius Kabi AG
  • Metall Zug AG
  • Sunovion Pharmaceuticals Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年氣霧劑輸送設備市場：提供新機會的國家
  • 2029 年氣霧劑輸送設備市場：細分市場帶來新機會
  • 2029 年氣霧劑輸送設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29347u

Aerosol delivery devices are specialized medical tools designed to administer medication as a mist or aerosol directly into the lungs. These devices are essential for treating respiratory conditions by precisely delivering therapeutic agents. Their primary goal is to ensure the effective and targeted distribution of medication within the respiratory system.

There are several types of aerosol delivery devices available, including dry powder inhalers, measured-dose inhalers, and nebulizers. Dry powder inhalers release medication in a powdered form, activated by the user's breath, and are utilized for conditions such as asthma, chronic obstructive pulmonary disease, cystic fibrosis, and other non-respiratory ailments. These devices are typically distributed through retail pharmacies, hospital pharmacies, and e-commerce platforms.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The aerosol delivery devices market research report is one of a series of new reports from the business research company that provides aerosol delivery devices market statistics, including aerosol delivery devices industry global market size, regional shares, competitors with an aerosol delivery devices market share, detailed aerosol delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the aerosol delivery devices industry. This aerosol delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aerosol delivery devices market size has grown strongly in recent years. It will grow from $47.6 billion in 2024 to $51.24 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases, regulatory approvals, growing adoption of portable devices, rising healthcare expenditure, increasing awareness campaigns about respiratory health, government initiatives, and funding.

The aerosol delivery devices market size is expected to see strong growth in the next few years. It will grow to $68.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to expanding applications in chronic disease management, increasing R&D investments, rising demand for personalized medicine, rising air pollution levels leading to respiratory disorders, and aging population driving demand for respiratory treatments. Major trends in the forecast period include technological advancements, advancements in drug delivery systems, the introduction of generic alternatives, the development of biologics and specialty drugs for inhalation therapy, and advancements in nanotechnology for aerosol drug delivery.

The forecast of 7.7% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher costs for precision ultrasonic nebulizers from Japan and dose-counting mechanisms from Israel, increasing expenses for respiratory disease management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of respiratory diseases is anticipated to drive growth in the aerosol delivery device market. These diseases encompass various conditions affecting the airways, lungs, and respiratory system, attributed to factors such as air pollution, smoking, allergens, and respiratory infections. Aerosol delivery devices play a crucial role in treating respiratory diseases by efficiently administering medications such as bronchodilators and corticosteroids directly to the lungs, thereby enhancing therapeutic outcomes and patient compliance. According to data from the National Center for Health Statistics (NCHS) in May 2024, the prevalence of current asthma among adults in the United States increased from 8% in 2021 to 8.7% in 2022, with a corresponding rise in asthma episodes from 3.3% to 3.7% within the same period. Consequently, the growing prevalence of respiratory diseases is expected to propel the aerosol delivery device market forward.

Key players in the aerosol delivery device market are concentrating on developing innovative inhaler dose trackers to enhance medication adherence through user-friendly designs. These intelligent trackers, equipped with sensors and connectivity features, monitor medication usage in real-time, improving adherence and providing comprehensive data to patients and healthcare providers. For instance, in June 2024, Aseptika Ltd., a UK-based MedTech company, introduced the PUFFClicker3 Universal Inhaler, a pioneering smart inhaler dose counter compatible with various inhalers. It employs sensors to record each dose, offers real-time monitoring, features a user-friendly interface, and utilizes Bluetooth connectivity to sync with health apps. This innovation assists patients in adhering to medication schedules while equipping healthcare providers with valuable adherence information.

In January 2024, Kindeva Drug Delivery, a pharmaceutical company based in the United States, acquired Summit Biosciences Inc. for an undisclosed sum. This acquisition is intended to broaden Kindeva's portfolio in drug delivery technologies, with a specific focus on sterile drug products and nasal spray devices. By integrating Summit Biosciences, Kindeva aims to strengthen its market position and enhance its technological capabilities in these specialized areas. Summit Biosciences Inc., also based in the US, specializes in manufacturing aerosol delivery devices, including nasal sprays.

Major companies operating in the aerosol delivery devices market are Pfizer Inc, Merck & Co Inc, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc (GSK), 3M Company, Becton Dickinson and Company, Koninklijke Philips NV, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Draegerwerk AG & Co KGaA, Shionogi & Co Ltd, Hikma Pharmaceuticals PLC, Chiesi Farmaceutici SpA, Vectura Group plc, Fresenius Kabi AG, Metall Zug AG, Sunovion Pharmaceuticals Inc., Omron Healthcare, Inc., PARI GmbH, Aerogen Inc, Clement Clarke International Ltd, Iconovo AB

North America was the largest region in the aerosol delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aerosol delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aerosol delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aerosol delivery devices market consists of sales of soft mist inhalers, spacer devices, breath-actuated inhalers, and topical spray bottles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aerosol Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aerosol delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aerosol delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aerosol delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Application: Asthma; Chronic Obstructive Pulmonary Disease; Cystic Fibrosis; Non Respiratory Diseases
  • 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; E Commerce
  • Subsegments:
  • 1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs; Multi-Dose DPIs
  • 2) By Metered Dose Inhalers (MDIs): Conventional MDIs; MDIs With Spacer/Chamber
  • 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
  • Companies Mentioned: Pfizer Inc; Merck & Co Inc; AstraZeneca plc; Abbott Laboratories; Novartis AG; GlaxoSmithKline plc (GSK); 3M Company; Becton Dickinson and Company; Koninklijke Philips NV; Viatris Inc.; Teva Pharmaceutical Industries Ltd; Sandoz International GmbH; Draegerwerk AG & Co KGaA; Shionogi & Co Ltd; Hikma Pharmaceuticals PLC; Chiesi Farmaceutici SpA; Vectura Group plc; Fresenius Kabi AG; Metall Zug AG; Sunovion Pharmaceuticals Inc.; Omron Healthcare Inc.; PARI GmbH; Aerogen Inc; Clement Clarke International Ltd; Iconovo AB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aerosol Delivery Devices Market Characteristics

3. Aerosol Delivery Devices Market Trends And Strategies

4. Aerosol Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Aerosol Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Aerosol Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Aerosol Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Aerosol Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Aerosol Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Aerosol Delivery Devices Total Addressable Market (TAM)

6. Aerosol Delivery Devices Market Segmentation

  • 6.1. Global Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Cystic Fibrosis
  • Non Respiratory Diseases
  • 6.3. Global Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail Pharmacies
  • Hospital Pharmacies
  • E Commerce
  • 6.4. Global Aerosol Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers (DPIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose DPIs
  • Multi-Dose DPIs
  • 6.5. Global Aerosol Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers (MDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional MDIs
  • MDIs With Spacer/Chamber
  • 6.6. Global Aerosol Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

7. Aerosol Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Aerosol Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Aerosol Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aerosol Delivery Devices Market

  • 8.1. Asia-Pacific Aerosol Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aerosol Delivery Devices Market

  • 9.1. China Aerosol Delivery Devices Market Overview
  • 9.2. China Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aerosol Delivery Devices Market

  • 10.1. India Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aerosol Delivery Devices Market

  • 11.1. Japan Aerosol Delivery Devices Market Overview
  • 11.2. Japan Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aerosol Delivery Devices Market

  • 12.1. Australia Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aerosol Delivery Devices Market

  • 13.1. Indonesia Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aerosol Delivery Devices Market

  • 14.1. South Korea Aerosol Delivery Devices Market Overview
  • 14.2. South Korea Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aerosol Delivery Devices Market

  • 15.1. Western Europe Aerosol Delivery Devices Market Overview
  • 15.2. Western Europe Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aerosol Delivery Devices Market

  • 16.1. UK Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aerosol Delivery Devices Market

  • 17.1. Germany Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aerosol Delivery Devices Market

  • 18.1. France Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aerosol Delivery Devices Market

  • 19.1. Italy Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aerosol Delivery Devices Market

  • 20.1. Spain Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aerosol Delivery Devices Market

  • 21.1. Eastern Europe Aerosol Delivery Devices Market Overview
  • 21.2. Eastern Europe Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aerosol Delivery Devices Market

  • 22.1. Russia Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aerosol Delivery Devices Market

  • 23.1. North America Aerosol Delivery Devices Market Overview
  • 23.2. North America Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aerosol Delivery Devices Market

  • 24.1. USA Aerosol Delivery Devices Market Overview
  • 24.2. USA Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aerosol Delivery Devices Market

  • 25.1. Canada Aerosol Delivery Devices Market Overview
  • 25.2. Canada Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aerosol Delivery Devices Market

  • 26.1. South America Aerosol Delivery Devices Market Overview
  • 26.2. South America Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aerosol Delivery Devices Market

  • 27.1. Brazil Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aerosol Delivery Devices Market

  • 28.1. Middle East Aerosol Delivery Devices Market Overview
  • 28.2. Middle East Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aerosol Delivery Devices Market

  • 29.1. Africa Aerosol Delivery Devices Market Overview
  • 29.2. Africa Aerosol Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Aerosol Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Aerosol Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aerosol Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Aerosol Delivery Devices Market Competitive Landscape
  • 30.2. Aerosol Delivery Devices Market Company Profiles
    • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Aerosol Delivery Devices Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline plc (GSK)
  • 31.2. 3M Company
  • 31.3. Becton Dickinson and Company
  • 31.4. Koninklijke Philips NV
  • 31.5. Viatris Inc.
  • 31.6. Teva Pharmaceutical Industries Ltd
  • 31.7. Sandoz International GmbH
  • 31.8. Draegerwerk AG & Co KGaA
  • 31.9. Shionogi & Co Ltd
  • 31.10. Hikma Pharmaceuticals PLC
  • 31.11. Chiesi Farmaceutici SpA
  • 31.12. Vectura Group plc
  • 31.13. Fresenius Kabi AG
  • 31.14. Metall Zug AG
  • 31.15. Sunovion Pharmaceuticals Inc.

32. Global Aerosol Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aerosol Delivery Devices Market

34. Recent Developments In The Aerosol Delivery Devices Market

35. Aerosol Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Aerosol Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Aerosol Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Aerosol Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer